DCGI approves market authorisation for SII's Covid vaccine Covovax as heterologous booster dose

"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommended for market authorisation of Covid jab Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin," an official source said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2EiTglA
via IFTTT